Professor Nicholas A. Peppas has been elected a Corresponding Member of the Real Academia Nacional de Farmacia (Royal Academy of Pharmacy of Spain).

Established in 1737 by King Philip V, the Royal Academy of Pharmacy of Spain is one of the Royal Academies belonging to the Institute of Spain under the reigning King of Spain, Juan Carlos I. The Academy is composed of 50 academicians and 173 corresponding academicians worldwide, who represent excellence and the highest scientific and intellectual merit in the field.

Dr. Peppas will be inducted and give an inaugural lecture in Madrid, Spain, on April 25, 2012.

He is also a member of three U.S. academies: the National Academy of Engineering; the Institute of Medicine; and the Academy of Medicine, Engineering, and Sciences of Texas. Additionally, he is a member of the National Academy of France.

As leader in biomaterials, drug delivery, and pharmaceutical bioengineering, Dr. Peppas' research blends modern molecular and cellular biology with ngineering to create innovative medical systems and devices for patient treatment.

He joined The University of Texas at Austin in 2003 as the Fletcher Stuckey Pratt Chair in Engineering, and professor of biomedical engineering, chemical engineering, and pharmacy. Since 2009, he has served as chair of the Department of Biomedical Engineering.

He has received numerous academic distinctions from the American Institute for Medical and Biological Engineering, the American Institute of Chemical Engineers, the Society for Biomaterials, and the Controlled Release Society, among many others.